GGrantIndex
← Leaderboards

Vibha N Lama

University Of Michigan At Ann Arbor

$11,271,662
Attributed
$11,271,662
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.3M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,271,662 · 4

By mechanism

R01$10,597,270 · 3
K23$674,392 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Others in their field

Top investigators on “Lung Transplantation

Research focus

Lung TransplantationPhenotypeLungSyndromeTransplant RecipientsTransplantationPathogenesisCellsSignal TransductionFibrosisIn VivoMesenchymalAllograftingLung AllograftChronicBronchiolitis ObliteransPreventPathway InteractionsPlayInvestigationPreclinical StudyAutocrineFibrogenesisCollagen

Grant awards (27)

Pathogenesis of Restrictive Allograft Syndrome Post-Lung Transplantation$661,951
R01 · FY2025 · HL · contact PI
Pathogenesis of Restrictive Allograft Syndrome Post-Lung Transplantation$629,587
R01 · FY2024 · HL · contact PI
Pathogenesis of Restrictive Allograft Syndrome Post-Lung Transplantation$671,112
R01 · FY2023 · HL · contact PI
Translational Dysregulation Driving Mesenchymal Cell Fibrogenic Transformation and Chronic Lung Allograft Dysfunction$574,636
R01 · FY2023 · HL · contact PI
Translational Dysregulation Driving Mesenchymal Cell Fibrogenic Transformation and Chronic Lung Allograft Dysfunction$1
R01 · FY2023 · HL · contact PI
Pathogenesis of Restrictive Allograft Syndrome Post-Lung Transplantation$701,112
R01 · FY2022 · HL · contact PI
Translational Dysregulation Driving Mesenchymal Cell Fibrogenic Transformation and Chronic Lung Allograft Dysfunction$595,447
R01 · FY2022 · HL · contact PI
Translational Dysregulation Driving Mesenchymal Cell Fibrogenic Transformation and Chronic Lung Allograft Dysfunction$625,447
R01 · FY2021 · HL · contact PI
Translational Dysregulation Driving Mesenchymal Cell Fibrogenic Transformation and Chronic Lung Allograft Dysfunction$574,637
R01 · FY2020 · HL · contact PI
Role of Resident Mesenchymal Stem Cells in Lung Allograft Rejection$399,125
R01 · FY2018 · HL · contact PI
Autotaxin Lysophophatidic acid pathway in bronchiolitis obliterans post-lung tran$490,549
R01 · FY2017 · HL · contact PI
Role of Resident Mesenchymal Stem Cells in Lung Allograft Rejection$399,125
R01 · FY2017 · HL · contact PI
Autotaxin Lysophophatidic acid pathway in bronchiolitis obliterans post-lung tran$498,977
R01 · FY2016 · HL · contact PI
Role of Resident Mesenchymal Stem Cells in Lung Allograft Rejection$429,125
R01 · FY2016 · HL · contact PI
Autotaxin Lysophophatidic acid pathway in bronchiolitis obliterans post-lung tran$522,606
R01 · FY2015 · HL · contact PI
Role of Resident Mesenchymal Stem Cells in Lung Allograft Rejection$399,876
R01 · FY2015 · HL · contact PI
Autotaxin Lysophophatidic acid pathway in bronchiolitis obliterans post-lung tran$518,786
R01 · FY2014 · HL · contact PI
Role of resident mesenchymal stem cells in lung allograft rejection$364,033
R01 · FY2013 · HL · contact PI
Role of resident mesenchymal stem cells in lung allograft rejection$382,388
R01 · FY2012 · HL · contact PI
Role of resident mesenchymal stem cells in lung allograft rejection$386,250
R01 · FY2011 · HL · contact PI
Role of resident mesenchymal stem cells in lung allograft rejection$386,250
R01 · FY2010 · HL · contact PI
Role of resident mesenchymal stem cells in lung allograft rejection$386,250
R01 · FY2009 · HL · contact PI
Fibroproliferation in Bronchiolitis Obliterans Syndrome$135,000
K23 · FY2008 · HL · contact PI
Fibroproliferation in Bronchiolitis Obliterans Syndrome$135,000
K23 · FY2007 · HL · contact PI
Fibroproliferation in Bronchiolitis Obliterans Syndrome$135,000
K23 · FY2006 · HL · contact PI
Fibroproliferation in Bronchiolitis Obliterans Syndrome$134,696
K23 · FY2005 · HL
Fibroproliferation in Bronchiolitis Obliterans Syndrome$134,696
K23 · FY2004 · HL